Methicillin-Resistant Staphylococcus aureus Infections.

Author Information
  1. Farr: Box 473, University of Virginia Health System, Charlottesville, VA 22908, USA.

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) has continued to spread and cause serious nosocomial infections. Failure to control MRSA may result in higher rates of use of glycopeptides, which may, in turn, lead to higher rates of glycopeptide resistance. Resistance to glycopeptides has recently begun to appear in S. aureus. Transfer of glycopeptide-resistance genes from enterococci to S. aureus has been documented in laboratory experiments but has not yet been found in clinical isolates. Over time, MRSA is becoming more common in various subsets of the general population. Some studies claim that many MRSA-colonized outpatients and their close contacts have had no health care contacts, but these studies have usually not considered contacts in outpatient clinics. Several other recent studies have found that all or a vast majority of patients with MRSA have had frequent contact with health care providers. Failure to wash hands and disinfect equipment between patients, which has been commonly seen in studies of health care worker compliance with infection control measures, may explain much of the continuing spread. The source of spread of antibiotic-resistant microbes can be likened to an iceberg, with clinically obvious infections representing the tip of the iceberg and most of the spread coming from clinically inapparent colonized patients who represent most of the reservoir for transmission. Surveillance cultures to identify this reservoir are important to the control of spread with effective barrier precautions. Such precautions have been shown to reduce the spread of MRSA 15.6-fold compared with standard precautions.

References

  1. N Engl J Med. 1998 Dec 31;339(27):2025-6; author reply 2026-7 [PMID: 9882207]
  2. Ann Intern Med. 1992 Sep 1;117(5):390-8 [PMID: 1503330]
  3. Anaesthesia. 1997 Feb;52(2):163-5 [PMID: 9059102]
  4. Infect Control Hosp Epidemiol. 1996 Jan;17(1):53-80 [PMID: 8789689]
  5. J Laryngol Otol. 1997 Sep;111(9):874-6 [PMID: 9373559]
  6. Eur J Clin Microbiol Infect Dis. 1994 Jan;13(1):50-5 [PMID: 8168564]
  7. JAMA. 1998 Feb 25;279(8):593-8 [PMID: 9486753]
  8. J Infect Dis. 1981 Dec;144(6):575-82 [PMID: 6977003]
  9. J Trauma. 1999 Feb;46(2):346-9 [PMID: 10029046]
  10. Ann Intern Med. 1988 Oct 15;109(8):619-24 [PMID: 3421575]
  11. JAMA. 1993 Feb 3;269(5):598-602 [PMID: 8240468]
  12. Ann Intern Med. 1982 Sep;97(3):309-17 [PMID: 7114627]
  13. Lancet. 1997 Aug 2;350(9074):323-5 [PMID: 9251636]
  14. JAMA. 1995 Aug 23-30;274(8):639-44 [PMID: 7637145]
  15. JAMA. 1997 Sep 17;278(11):901-4 [PMID: 9302241]
  16. Arch Intern Med. 1997 Apr 14;157(7):786-90 [PMID: 9125011]
  17. JAMA. 1998 Mar 18;279(11):875-7 [PMID: 9516004]
  18. Diagn Microbiol Infect Dis. 1996 Feb;24(2):93-100 [PMID: 9147915]
  19. Ann Intern Med. 1999 Jan 19;130(2):126-30 [PMID: 10068358]
  20. Am J Infect Control. 1995 Apr;23(2):87-94 [PMID: 7639408]
  21. J Pediatr. 1999 Feb;134(2):252 [PMID: 9931544]
  22. Am J Infect Control. 1988 Oct;16(5):185-92 [PMID: 3264121]
  23. Clin Infect Dis. 1994 Dec;19(6):1123-8 [PMID: 7888543]
  24. FEMS Microbiol Lett. 1992 Jun 1;72(2):195-8 [PMID: 1505742]
  25. Infect Control Hosp Epidemiol. 1995 Dec;16(12):686-96 [PMID: 8683086]
  26. Ann Intern Med. 1996 May 15;124(10):884-90 [PMID: 8610917]
  27. JAMA. 1998 Feb 25;279(8):623-4 [PMID: 9486761]
  28. Ann Intern Med. 1996 Jul 15;125(2):I54 [PMID: 9446494]
  29. N Engl J Med. 1999 Feb 18;340(7):493-501 [PMID: 10021469]
  30. Lancet. 1997 Mar 8;349(9053):729 [PMID: 9078221]
  31. J Hosp Infect. 1991 Jun;18 Suppl A:65-72 [PMID: 1679829]
  32. Infect Control Hosp Epidemiol. 1998 Mar;19(3):181-5 [PMID: 9552186]
  33. J Infect Dis. 1998 Aug;178(2):577-80 [PMID: 9697748]
  34. Am J Med. 1998 Aug;105(2):164-6 [PMID: 9727825]
  35. Am J Public Health Nations Health. 1962 Nov;52:1828-43 [PMID: 13937212]
  36. Clin Orthop Relat Res. 1996 Apr;(325):239-44 [PMID: 8998882]
  37. J Hosp Infect. 1988 Aug;12(2):91-101 [PMID: 2905726]
  38. Ann Intern Med. 1991 Nov 1;115(9):674-80 [PMID: 1929035]
  39. Arch Intern Med. 1998 Apr 27;158(8):895-9 [PMID: 9570176]
  40. Lancet. 1998 Apr 18;351(9110):1212 [PMID: 9643727]
  41. Infect Control Hosp Epidemiol. 1988 Jun;9(6):255-60 [PMID: 3136202]
  42. Antimicrob Agents Chemother. 1990 Jun;34(6):1227-31 [PMID: 2393284]
  43. Arch Intern Med. 1998 Jan 26;158(2):182-9 [PMID: 9448557]
  44. Infect Dis Clin North Am. 1989 Dec;3(4):901-13 [PMID: 2687368]
  45. J Clin Microbiol. 1989 Jul;27(7):1471-6 [PMID: 2768437]
  46. Am J Med. 1998 May 29;104(5A):7S-10S [PMID: 9684652]
  47. Lancet. 1998 Feb 21;351(9102):602 [PMID: 9492814]
  48. Arch Surg. 1997 Dec;132(12):1320-5 [PMID: 9403537]
  49. Ann Surg. 1996 Nov;224(5):665-71 [PMID: 8916881]
  50. N Engl J Med. 1999 Feb 18;340(7):517-23 [PMID: 10021472]
  51. Lancet. 1998 Jul 11;352(9122):145-6 [PMID: 9672301]
  52. Am J Epidemiol. 1996 Mar 1;143(5):496-504 [PMID: 8610665]
  53. Lancet. 1998 Feb 21;351(9102):601-2 [PMID: 9492813]
  54. N Engl J Med. 1992 Jul 9;327(2):88-93 [PMID: 1285746]
  55. Ann Intern Med. 1996 Mar 15;124(6):539-47 [PMID: 8597316]
  56. Am J Clin Pathol. 1996 Nov;106(5):600-5 [PMID: 8929469]
  57. J Infect Dis. 1998 Jul;178(1):164-71 [PMID: 9652436]
  58. N Engl J Med. 1999 Feb 18;340(7):556-7 [PMID: 10021477]
  59. J Infect. 1996 Jul;33(1):11-3 [PMID: 8842988]
  60. J Clin Microbiol. 1992 Mar;30(3):670-4 [PMID: 1551985]
  61. Ann Otol Rhinol Laryngol. 1997 Sep;106(9):751-2 [PMID: 9302906]
  62. Lancet. 1998 May 30;351(9116):1614-9 [PMID: 9620715]

Word Cloud

Created with Highcharts 10.0.0spreadMRSAaureusstudiescontrolmaycontactshealthcarepatientsprecautionsStaphylococcusinfectionsFailurehigherratesglycopeptidesSfoundicebergclinicallyreservoirMethicillin-resistantcontinuedcauseseriousnosocomialresultuseturnleadglycopeptideresistanceResistancerecentlybegunappearTransferglycopeptide-resistancegenesenterococcidocumentedlaboratoryexperimentsyetclinicalisolatestimebecomingcommonvarioussubsetsgeneralpopulationclaimmanyMRSA-colonizedoutpatientscloseusuallyconsideredoutpatientclinicsSeveralrecentvastmajorityfrequentcontactproviderswashhandsdisinfectequipmentcommonlyseenworkercomplianceinfectionmeasuresexplainmuchcontinuingsourceantibiotic-resistantmicrobescanlikenedobviousrepresentingtipcominginapparentcolonizedrepresenttransmissionSurveillanceculturesidentifyimportanteffectivebarriershownreduce156-foldcomparedstandardMethicillin-ResistantInfections

Similar Articles

Cited By